与硼替佐米用于多发性骨髓瘤相关的耳聋。 - Suppr

Suppr

超能文献

Deafness associated with the use of Bortezomib in multiple myeloma.

作者信息

Chim C S, Wong L G

出版信息

Acta Oncol. 2008;47(2):323-4. doi: 10.1080/02841860701558823.

DOI:10.1080/02841860701558823

PMID:17851876

Abstract

摘要

相似文献

Deafness associated with the use of Bortezomib in multiple myeloma.

Acta Oncol. 2008;47(2):323-4. doi: 10.1080/02841860701558823.

Severe epidermal necrolysis after bortezomib treatment for multiple myeloma.

Acta Haematol. 2007;118(2):65-7. doi: 10.1159/000102604. Epub 2007 May 15.

The impact of bortezomib on the risk of thrombosis in multiple myeloma.

Leuk Res. 2011 Feb;35(2):145-6. doi: 10.1016/j.leukres.2010.09.017. Epub 2010 Oct 16.

Pulmonary fibrosis in a myeloma patient on bortezomib treatment. A new severe adverse effect of a new drug.

Am J Hematol. 2007 Jun;82(6):502-3. doi: 10.1002/ajh.20891.

Optimizing bortezomib treatment in patients with relapsed multiple myeloma.

Clin Adv Hematol Oncol. 2006 May;4(5):4-5; discussion 8; suppl 13.

Severe pulmonary complications after bortezomib treatment in multiple myeloma.

Hematol Oncol. 2010 Mar;28(1):49-52. doi: 10.1002/hon.924.

Hyperlipidemia in a myeloma patient after bortezomib treatment.

Leuk Res. 2010 Sep;34(9):e250. doi: 10.1016/j.leukres.2010.03.025. Epub 2010 Apr 3.

Bortezomib-induced acute pancreatitis.

JOP. 2010 May 5;11(3):275-6.

Bortezomib increases survival of patients with relapsed multiple myeloma.

Health News. 2005 Sep;11(9):9.

Adenovirus-associated hemorrhagic cystitis in a patient with plasma cell myeloma treated with bortezomib.

Leuk Res. 2009 Aug;33(8):e106. doi: 10.1016/j.leukres.2009.02.021. Epub 2009 Mar 13.

引用本文的文献

Hearing Loss in a Patient with Waldenstrom Macroglobulinemia Receiving Bortezomib.

Case Rep Oncol. 2024 Jun 18;17(1):653-657. doi: 10.1159/000539453. eCollection 2024 Jan-Dec.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Deafness associated with the use of Bortezomib in multiple myeloma.

作者信息

Chim C S, Wong L G

出版信息

Acta Oncol. 2008;47(2):323-4. doi: 10.1080/02841860701558823.

DOI:10.1080/02841860701558823

PMID:17851876

Abstract

摘要

相似文献

Deafness associated with the use of Bortezomib in multiple myeloma.

Acta Oncol. 2008;47(2):323-4. doi: 10.1080/02841860701558823.

Severe epidermal necrolysis after bortezomib treatment for multiple myeloma.

Acta Haematol. 2007;118(2):65-7. doi: 10.1159/000102604. Epub 2007 May 15.

The impact of bortezomib on the risk of thrombosis in multiple myeloma.

Leuk Res. 2011 Feb;35(2):145-6. doi: 10.1016/j.leukres.2010.09.017. Epub 2010 Oct 16.

Pulmonary fibrosis in a myeloma patient on bortezomib treatment. A new severe adverse effect of a new drug.

Am J Hematol. 2007 Jun;82(6):502-3. doi: 10.1002/ajh.20891.

Optimizing bortezomib treatment in patients with relapsed multiple myeloma.

Clin Adv Hematol Oncol. 2006 May;4(5):4-5; discussion 8; suppl 13.

Severe pulmonary complications after bortezomib treatment in multiple myeloma.

Hematol Oncol. 2010 Mar;28(1):49-52. doi: 10.1002/hon.924.

Hyperlipidemia in a myeloma patient after bortezomib treatment.

Leuk Res. 2010 Sep;34(9):e250. doi: 10.1016/j.leukres.2010.03.025. Epub 2010 Apr 3.

Bortezomib-induced acute pancreatitis.

JOP. 2010 May 5;11(3):275-6.

Bortezomib increases survival of patients with relapsed multiple myeloma.

Health News. 2005 Sep;11(9):9.

Adenovirus-associated hemorrhagic cystitis in a patient with plasma cell myeloma treated with bortezomib.

Leuk Res. 2009 Aug;33(8):e106. doi: 10.1016/j.leukres.2009.02.021. Epub 2009 Mar 13.

引用本文的文献

Hearing Loss in a Patient with Waldenstrom Macroglobulinemia Receiving Bortezomib.

Case Rep Oncol. 2024 Jun 18;17(1):653-657. doi: 10.1159/000539453. eCollection 2024 Jan-Dec.